Table 2. Effects of 24 h, 48 h and 6 days exposures to TBBPA on IL -1 β secretion from monocyte depleted PBMCs.
24 h | Interleukin 1 beta secreted in pg/mL (mean±S.D.) | |||
---|---|---|---|---|
| ||||
[TBBPA] μM | F 175 | F 177 | F 180 | F 184 |
0 | 1751±31 | 1103±43 | 4465±8 | 714±103 |
0.05 | 1417±142* | 2393±457* | 4807±139* | 6869±345* |
0.1 | 1198±23* | 1898±446 | 4088±79* | 5478±856* |
0.25 | 1527±106 | 1098±19- | 2777±33* | 1743±233* |
0.5 | 1409±73* | 608±219 | 2268±178* | 1294±36* |
1 | 778±30* | 670±58* | 1645±157* | 1311±635* |
2.5 | 790±71* | 308±41* | 957±129* | 938±±34 |
5 | 578±18* | 179±50* | 1544±80* | 737±125 |
| ||||
48 h | Interleukin 1 beta secreted in pg/mL (mean±S.D.) | |||
| ||||
[TBBPA] μM | F 175 | F 177 | F 180 | F 184 |
0 | 3086±173 | 2381±189 | 5539±216 | 618±35 |
0.05 | 3061±338 | 2178±124 | 4826±229* | 765±166 |
0.1 | 2691±354 | 1918±48* | 4212±129* | 595±115 |
0.25 | 1850±140* | 2220±263 | 2726±167* | 720±93 |
0.5 | 3045±116 | 1918±24* | 2563±79* | 573±94 |
1 | 3014±102 | 1480±1128 | 2720±239* | 601±10 |
2.5 | 1594±77* | 1371±48* | 2475±56* | 1415±93* |
5 | 1178±31* | 1272±15* | 4680±117* | 2347±81* |
| ||||
6d | Interleukin 1 beta secreted in pg/mL (mean±S.D.) | |||
| ||||
[TBBPA] μM | F 175 | F 177 | F 180 | F 184 |
0 | 1458±15 | 3054±253 | 2960±128 | 371±26 |
0.05 | 4149±113* | 13725±175* | 2938±108 | 2975±450* |
0.1 | 3238±42* | 3025±78 | 2321±168* | 1894±336* |
0.25 | 2918±192* | 5479±189* | 1857±234* | 1998±263* |
0.5 | 2468±137* | 4000±113* | 780±55* | 1360±156* |
1 | 1417±22 | 2167±69* | 1285±110* | 1429±88* |
2.5 | 3426±82* | 2646±182 | 1915±135* | 1348±302* |
5 | 559±21* | 1946±71* | 1951±41* | 1544±81* |
Values are mean±S.D. of triplicate determinations.
Indicates a significant change in secretion compared to control cells (cells treated with vehicle alone), p<0.05